Parallel Advisors’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.34M | Buy |
2,837
+177
| +7% | +$89.1K | 0.02% | 384 |
|
|
2025
Q4 | $1.24M | Buy |
2,660
+124
| +5% | +$57.6K | 0.02% | 386 |
|
|
2025
Q3 | $1.08M | Sell |
2,536
-23
| -0.9% | -$8.91K | 0.02% | 407 |
|
|
2025
Q2 | $980K | Buy |
2,559
+251
| +11% | +$90.4K | 0.02% | 423 |
|
|
2025
Q1 | $797K | Buy |
2,308
+193
| +9% | +$62.1K | 0.02% | 450 |
|
|
2024
Q4 | $635K | Sell |
2,115
-9
| -0.4% | -$3.15K | 0.01% | 521 |
|
|
2024
Q3 | $864K | Buy |
2,124
+106
| +5% | +$38.8K | 0.02% | 418 |
|
|
2024
Q2 | $648K | Buy |
2,018
+71
| +4% | +$23.1K | 0.02% | 466 |
|
|
2024
Q1 | $649K | Buy |
1,947
+160
| +9% | +$48.9K | 0.02% | 453 |
|
|
2023
Q4 | $484K | Sell |
1,787
-211
| -11% | -$52.2K | 0.01% | 498 |
|
|
2023
Q3 | $492K | Sell |
1,998
-22
| -1% | -$6.02K | 0.02% | 464 |
|
|
2023
Q2 | $613K | Buy |
2,020
+116
| +6% | +$32.3K | 0.02% | 416 |
|
|
2023
Q1 | $502K | Buy |
1,904
+117
| +7% | +$29.7K | 0.02% | 463 |
|
|
2022
Q4 | $429K | Buy |
1,787
+117
| +7% | +$26.2K | 0.02% | 454 |
|
|
2022
Q3 | $307K | Buy |
1,670
+56
| +3% | +$11.2K | 0.01% | 531 |
|
|
2022
Q2 | $271K | Sell |
1,614
-330
| -17% | -$70.9K | 0.01% | 562 |
|
|
2022
Q1 | $496K | Sell |
1,944
-41
| -2% | -$10.3K | 0.02% | 431 |
|
|
2021
Q4 | $510K | Buy |
1,985
+21
| +1% | +$5.14K | 0.02% | 435 |
|
|
2021
Q3 | $477K | Buy |
1,964
+310
| +19% | +$75.8K | 0.02% | 414 |
|
|
2021
Q2 | $342K | Buy |
1,654
+239
| +17% | +$48.7K | 0.01% | 494 |
|
|
2021
Q1 | $266K | Buy |
1,415
+166
| +13% | +$29.3K | 0.01% | 540 |
|
|
2020
Q4 | $205K | Sell |
1,249
-278
| -18% | -$40.6K | 0.01% | 581 |
|
|
2020
Q3 | $190K | Buy |
1,527
+36
| +2% | +$4.46K | 0.01% | 579 |
|
|
2020
Q2 | $144K | Sell |
1,491
-270
| -15% | -$28.1K | 0.01% | 645 |
|
|
2020
Q1 | $158K | Sell |
1,761
-375
| -18% | -$48.6K | 0.01% | 527 |
|
|
2019
Q4 | $316K | Sell |
2,136
-521
| -20% | -$70K | 0.02% | 390 |
|
|
2019
Q3 | $320K | Buy |
2,657
+408
| +18% | +$52.7K | 0.03% | 364 |
|
|
2019
Q2 | $304K | Buy |
2,249
+486
| +28% | +$61.4K | 0.03% | 343 |
|
|
2019
Q1 | $230K | Buy |
1,763
+367
| +26% | +$49.3K | 0.03% | 366 |
|
|
2018
Q4 | $173K | Buy |
1,396
+78
| +6% | +$10.5K | 0.02% | 391 |
|
|
2018
Q3 | $183K | Hold |
1,318
| – | – | 0.02% | 410 |
|
|
2018
Q2 | $135K | Sell |
1,318
-19
| -1% | -$1.92K | 0.02% | 465 |
|
|
2018
Q1 | $130K | Hold |
1,337
| – | – | 0.02% | 421 |
|
|
2017
Q4 | $117K | Buy |
1,337
+578
| +76% | +$46.4K | 0.02% | 442 |
|
|
2017
Q3 | $59K | Sell |
759
-140
| -16% | -$11.3K | 0.01% | 625 |
|
|
2017
Q2 | $72K | Buy |
899
+158
| +21% | +$13.4K | 0.01% | 579 |
|
|
2017
Q1 | $61K | Buy |
741
+210
| +40% | +$17.5K | 0.01% | 594 |
|
|
2016
Q4 | $39K | Buy |
+531
| New | +$39.8K | 0.01% | 662 |
|
Other funds holding HCA
VCM
VPM
Parallel Advisors's HCA Position: Q1 2026 in Review
Parallel Advisors increased its HCA Healthcare (HCA) stake by 6.7% in Q1 2026, buying an estimated $89.1K and bringing the position to 2,837 shares worth $1.34M. The position accounts for 0.02% of the portfolio, ranked #384.
Parallel Advisors first reported a position in HCA in Q4 2016 and has held it in 38 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Parallel Advisors held 2,837 shares of HCA Healthcare worth $1.34M as of Q1 2026.
- Parallel Advisors bought 177 HCA Healthcare shares in Q1 2026, an estimated $89.1K.
- HCA Healthcare made up 0.02% of Parallel Advisors's portfolio in Q1 2026, its #384 holding.
- Parallel Advisors first reported a position in HCA Healthcare in Q4 2016 and has held it in 38 quarters since.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.